Cited by 719Immune cells in cancerAtherosclerosis and Cardiovascular DiseasesPhagocytosis and Immune Regulation

Fate Mapping via Ms4a3-Expression History Traces Monocyte-Derived Cells

Open access
Liu, Zhaoyuan, Gu, Yaqi, Chakarov, Svetoslav, Bleriot, Camille, Kwok, Immanuel, Chen, Xin, Shin, Amanda, Huang, Weijie +9 more·2019·Cell

Published version of a preprint

Abstract

Most tissue-resident macrophage (RTM) populations are seeded by waves of embryonic hematopoiesis and are self-maintained independently of a bone marrow contribution during adulthood. A proportion of RTMs, however, is constantly replaced by blood monocytes, and their functions compared to embryonic RTMs remain unclear. The kinetics and extent of the contribution of circulating monocytes to RTM replacement during homeostasis, inflammation, and disease are highly debated. Here, we identified Ms4a3 as a specific gene expressed by granulocyte-monocyte progenitors (GMPs) and subsequently generated Ms4a3 TdT reporter, Ms4a3 Cre, and Ms4a3 CreERT2 fate-mapping models. These models traced efficiently monocytes and granulocytes, but no lymphocytes or tissue dendritic cells. Using these models, we precisely quantified the contribution of monocytes to the RTM pool during homeostasis and inflammation. The unambiguous identification of monocyte-derived cells will permit future studies of their function under any condition.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cell.2019.08.009

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Clonal hematopoiesis (CH) prominently involves variants of epigenetic regulatory genes, such as DNMT3A and TET2.

    “CH prominently involves variants of epigenetic regulatory genes, such as DNMT3A and TET2, which constitute an increased risk for hematologic malignancies, cardiovascular events and stroke 34,45,70,71 .”

    From Clonal hematopoiesis-associated motoric deficits caused by monocyte-derived microglia accumulating in aging mice (2025) · cites this paper as [45]

    The Introduction (p. 4) describes Ms4a3-based tracing of monocyte progenitors, not clonal hematopoiesis. Searches for DNMT3A, TET2, epigenetic regulators, and clonal hematopoiesis found no passage in our copy addressing the attributed claim. (LLM, conf=0.75)

    Experimental — accuracy not yet measured
  • CH variants such as DNMT3A and TET2 constitute an increased risk for hematologic malignancies, cardiovascular events and stroke.

    “CH prominently involves variants of epigenetic regulatory genes, such as DNMT3A and TET2, which constitute an increased risk for hematologic malignancies, cardiovascular events and stroke 34,45,70,71 .”

    From Clonal hematopoiesis-associated motoric deficits caused by monocyte-derived microglia accumulating in aging mice (2025) · cites this paper as [45]

    The Introduction (p. 4) describes an Ms4a3 fate-mapping model, and the Discussion (pp. 15–16) addresses MS4A3 expression and cell-cycle regulation. Searches for DNMT3A, TET2, clonal hematopoiesis, cardiovascular risk, and stroke found no passage in our copy addressing the claimed disease risks. (LLM, conf=0.76)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 5

  1. Adra, C.N., Lelias, J.M., Kobayashi, H., Kaghad, M., Morrison, P., Rowley, J.D., and Lim, B. (1994). Cloning of the cDNA for a hematopoietic cell-specific protein related to CD20 and the beta subunit of the high-affinity IgE receptor: evidence for a family of proteins with four membrane-spanning regions. Proceedings of the National Academy of Sciences of the United States of America 91 , 10178-10182.
  2. Chinami, M., Yano, Y., Yang, X., Salahuddin, S., Moriyama, K., Shiroishi, M., Turner, H., Shirakawa, T., and Adra, C.N. (2005). Binding of HTm4 to cyclin-dependent kinase (Cdk)-associated phosphatase (KAP).Cdk2.cyclin A complex enhances the phosphatase activity of KAP, dissociates cyclin A, and facilitates KAP dephosphorylation of Cdk2. The Journal of biological chemistry 280 , 17235-17242.
  3. Donato, J.L., Ko, J., Kutok, J.L., Cheng, T., Shirakawa, T., Mao, X.Q., Beach, D., Scadden, D.T., Sayegh, M.H., and Adra, C.N. (2002). Human HTm4 is a hematopoietic cell cycle regulator. The Journal of clinical investigation 109 , 51-58.
  4. Guilliams, M., De Kleer, I., Henri, S., Post, S., Vanhoutte, L., De Prijck, S., Deswarte, K., Malissen, B., Hammad, H., and Lambrecht, B.N. (2013). Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF. The Journal of experimental medicine 210 , 1977-1992.
  5. Kutok, J.L., Yang, X., Folkerth, R., and Adra, C.N. (2011). Characterization of the expression of HTm4 (MS4A3), a cell cycle regulator, in human peripheral blood cells and normal and malignant tissues. Journal of cellular and molecular medicine

Cited by

Sorted by citations

Authors
Liu, Z., Gu, Y., Chakarov, S., Bleriot, C., Kwok, I., Chen, X., Shin, A., Huang, W., Dress, R. J., Dutertre, C.-A., Schlitzer, A., Chen, J., Ng, L. G., Wang, H., Liu, Z., Su, B., & Ginhoux, F.
Affiliations
  • Shanghai Jiao Tong University (CN)
  • Agency for Science, Technology and Research (SG)
  • University of Bonn (DE)
Corresponding author
  • Su, Bing
  • Ginhoux, Florent
Venue
Cell
Publisher
Elsevier BV
Published
2019-09
Volume
178
Issue
6
Pages
1509-1525.e19
ISSN
0092-8674 (ISSN-L)
OpenAlex
W2971790873
Cited by
719
References
12
Citations by year
2026: 102 · 2025: 143 · 2024: 113 · 2023: 97 · 2022: 94 · 2021: 88 · 2020: 72 · 2019: 9
FWCI
26.27
Type
journal article
Language
en
Open access
Locations
  • Cell (publishedVersion)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed (publishedVersion)
Funders
Agency for Science, Technology and Research
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
  • Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
  • Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
Keywords
monocyte-derived cells, tissue-resident macrophages, CFU-GM, fate mapping, embryonic hematopoiesis, macrophage homeostasis, inflammation, granulocytes
MeSH terms
Animals, Granulocytes, Hematopoiesis, Homeostasis, Inflammation, Macrophages, Membrane Proteins, Monocytes, Gene Expression, Cell Cycle Proteins, Mice, Granulocyte-Macrophage Progenitor Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review